Published in Hepatitis Weekly, July 17th, 1995
Hepatitis A infects about 138,000 Americans annually and kills about 100. However, if treated promptly, the infection usually clears up in about two months - unlike the more severe, chronic hepatitis B.
The U.S. Food and Drug Administration (FDA) in February 1995 approved the nation's first hepatitis A vaccine, SmithKline Beecham's Havrix. The vaccine costs about $60 a shot, including the doctor visit. Two doses are needed.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly